相关实验视频

Updated: Jun 29, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

CT测定体积较低对功能衰退的影响:倾向性评分匹配分析

Tomohiro Kikuchi^1,2, Shouhei Hanaoka³, Takahiro Nakao⁴

¹Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. r1419kt@jichi.ac.jp.

Insights into imaging

|April 5, 2024

概括

低体积是功能下降的重要预测因素. 体积测量可以帮助识别有降低估计膜过率 (eGFR) 风险的人.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
放射学放射学是一门学科.
医疗成像医学成像

背景情况:

估计的淋巴细胞过率 (eGFR) 降低是慢性病进展的关键指标.
通过成像测量体积,可以提供有关健康的见解.
了解与EGFR下降相关的因素对于早期干预至关重要.

研究的目的:

调查体积低和随后的EGFR下降之间的关联.
评估EGFR类G2.2个体中体积的预测值.
探索成像指标对预测功能恶化的有用性.

主要方法:

从2006年至2017年,对5531名eGFR G2个体进行了回顾性分析.
开发一个3D U-net系统,用于CT图像上的自动体积测量.
1:1倾向分数匹配创造了397对低体积 (LKV) 和对照组.

主要成果:

低体积 (LKV) 定义为性别特异性的切线 (男性:337.5厘米3,女性:308.8厘米3).
在5年内,LKV是eGFR类别进展的显著风险因素 (aHR为1.64,p=0.02).
这项研究包括3220名平均年龄为60.0岁的个人.

结论:

低体积是随着时间的推移减少功能的一个重要预测因素.
体积测量可以帮助早期识别患有健康下降风险的个体.
像体积这样的成像指标可能有助于预测eGFR下降.

关键词:

慢性功能衰竭慢性功能衰竭淋巴细胞的过率是什么脏 - 脏 - 脏电脑断层扫描X射线扫描

更多相关视频

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

相关概念视频

Factors Affecting Renal Clearance: Renal Impairment

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...

Renal Clearance

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...